Trial intelligence / Profile preview

Early Treatment of Exacerbations in COPD With Advair

NCT02136875Phase 4Completed

Sponsor
McGill University Health Centre
Start
Jul 2008
Primary completion
Aug 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by McGill University Health Centre. Started Jul 2008; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02136875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02136875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call